SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-078585
Filing Date
2012-11-16
Accepted
2012-11-16 16:00:48
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20125_110q.htm 10-Q 1239608
2 EX-31.1 a12-20125_1ex31d1.htm EX-31.1 13260
3 EX-31.2 a12-20125_1ex31d2.htm EX-31.2 13097
4 EX-32.1 a12-20125_1ex32d1.htm EX-32.1 4762
5 EX-32.2 a12-20125_1ex32d2.htm EX-32.2 5275
  Complete submission text file 0001104659-12-078585.txt   8509002

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20120930.xml EX-101.INS 1117510
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycc-20120930.xsd EX-101.SCH 67622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycc-20120930_cal.xml EX-101.CAL 77388
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycc-20120930_def.xml EX-101.DEF 369976
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cycc-20120930_lab.xml EX-101.LAB 1092782
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycc-20120930_pre.xml EX-101.PRE 482728
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 121211675
SIC: 2834 Pharmaceutical Preparations